Status:
COMPLETED
A Randomized Controlled HD-tDCS Trial: Effects on Tinnitus Severity and Cognition
Lead Sponsor:
University Hospital, Antwerp
Collaborating Sponsors:
Universiteit Antwerpen
Conditions:
Tinnitus
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This randomized, placebo-controlled study will compare the effects of HD-tDCS (a non-invasive neuromodulation technique) with a sham stimulation. In the sham situation, patients will undergo an identi...
Eligibility Criteria
Inclusion
- Duration of tinnitus: \> 6 months
- 24 \< TFI score \< 90
- HADS depression subscale \< 12
- HADS anxiety subscale \< 12
- Hyperacusis questionnaire \< 40
- Dutch- or Flemish-speaking
Exclusion
- Somatic tinnitus
- Pregnancy
- Active middle ear pathology
- Hearing implants
- Known tumors in the head/neck region
- Patients having already had any other tinnitus treatment within the last 2 months
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2022
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT03754127
Start Date
January 1 2019
End Date
March 30 2022
Last Update
July 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Antwerp University Hospital
Antwerp, Edegem, Belgium, 2650